Ravimohan Shruthi, Tamuhla Neo, Nfanyana Kebatshabile, Ni Houping, Steenhoff Andrew P, Gross Robert, Weissman Drew, Bisson Gregory P
Department of Medicine, Division of Infectious Diseases and.
Botswana-UPenn Partnership, Gaborone.
Clin Infect Dis. 2017 May 15;64(10):1453-1456. doi: 10.1093/cid/cix155.
Correlates of death soon after antiretroviral therapy (ART) initiation remain unclear. We investigated the association between expression of CD39, a novel immune exhaustion marker, and early mortality in patients with human immunodeficiency virus/tuberculosis co-infection. Elevated pre-ART CD39+CD8+ T cell frequency was independently associated with mortality within 6 months of ART initiation.
抗逆转录病毒疗法(ART)开始后不久死亡的相关因素仍不清楚。我们研究了新型免疫耗竭标志物CD39的表达与人类免疫缺陷病毒/结核病合并感染患者早期死亡率之间的关联。ART开始前CD39+CD8+T细胞频率升高与ART开始后6个月内的死亡率独立相关。